Cost and health impact analysis of herpes zoster vaccination in Norway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost and health impact analysis of herpes zoster vaccination in Norway

Published:2021-09-12 Issue: Volume: Page:1-12
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Flem Elmira¹^ORCID,Graham Jonathan²,Yi Zinan²,Wisløff Torbjørn³,Johnson Kelly D.⁴

Affiliation:

1. Medical Affairs, Merck Sharp & Dohme Corp, Drammen, Norway

2. Health Economics, RTI Health Solutions, Research Triangle Park, North Carolina, USA

3. Department of Community Medicine, The Arctic University of Norway, Tromsø, Norway

4. Merck & Co., Inc, Center for Observational and Real-World Evidence (CORE), Kenilworth, New Jersey, USA

Funder

Merck and Co., Inc

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2021.1973893

Reference32 articles.

1. The burden of herpes zoster disease in Norway

2. Healthcare costs associated with varicella and herpes zoster in Norway

3. A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults

4. Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years

5. Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines;Side Effects of Drugs Annual;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP